On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-03-27
DOI
10.1093/jac/dkz162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen
- (2018) B.J. Werth et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dalbavancin in the treatment of different gram-positive infections: a real-life experience
- (2018) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16
- (2018) Michael A Pfaller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infectious Diseases Physicians’ Perspectives Regarding Injection Drug Use and Related Infections, United States, 2017
- (2018) Alison B Rapoport et al. Open Forum Infectious Diseases
- Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
- (2018) Jason P Burnham et al. Open Forum Infectious Diseases
- Short Course Antibiotic Therapy—Replacing Constantine Units with “Shorter Is Better”
- (2018) Noah Wald-Dickler et al. CLINICAL INFECTIOUS DISEASES
- Multiple-Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections
- (2017) Lucas T Schulz et al. PHARMACOTHERAPY
- A Little Bit of Dalba Goes a Long Way: Dalbavancin Use in a Vulnerable Patient Population
- (2017) Chloe Bryson-Cahn et al. Open Forum Infectious Diseases
- Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug Users
- (2017) Deanna J. Buehrle et al. Open Forum Infectious Diseases
- Optimizing the Clinical Use of Vancomycin
- (2016) Rocío Álvarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Review of vancomycin-induced renal toxicity: an update
- (2016) Oluwatoyin Bamgbola Therapeutic Advances in Endocrinology and Metabolism
- Use ofIn VitroVancomycin Testing Results To Predict Susceptibility to Oritavancin, a New Long-Acting Lipoglycopeptide
- (2015) Ronald N. Jones et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
- (2015) Michael W. Dunne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
- (2015) Larry M. Baddour et al. CIRCULATION
- Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study
- (2015) Anthony D. Bai et al. CLINICAL INFECTIOUS DISEASES
- What Medicare Is Missing: Table 1.
- (2015) Sara Keller et al. CLINICAL INFECTIOUS DISEASES
- 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults
- (2015) Elie F. Berbari et al. CLINICAL INFECTIOUS DISEASES
- Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation
- (2015) Dimitrios Farmakiotis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
- (2015) Michael W Dunne et al. Annals of Clinical Microbiology and Antimicrobials
- Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting
- (2015) V. Ektare et al. JOURNAL OF MEDICAL ECONOMICS
- Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
- (2014) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
- (2014) Dennis L. Stevens et al. CLINICAL INFECTIOUS DISEASES
- Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
- (2014) G. Ralph Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
- (2009) F. F. Arhin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America
- (2009) Leonard A. Mermel et al. CLINICAL INFECTIOUS DISEASES
- Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
- (2009) H. M. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increasing Antibiotic Resistance among Methicillin‐ResistantStaphylococcus aureusStrains
- (2008) George Sakoulas et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search